Abstract submissions for the US HUPO 2021 Conference are now closed. If you have questions or require assistance with your abstract submission, please contact the conference secretariat at USHUPO@ConferenceSolutionsinc.com.
The 17th Annual US HUPO Conference will accept abstracts poster presentation consideration from Monday, 12 October – Friday, 15 January 2021 at 23:59 Pacific Standard Time in the following topic areas:
Advances in Technology
Aging and Neurodegenerative Diseases
Biomarkers and Targeted MS Assays
Cellular Signaling and Systems Biology
Chemical Proteomics and Drug Discovery
Computational Proteomics and Data Science
Data Analysis and Visualization
Multi-omics: Methods and Applications
Glycoproteomics and Glycomics
Metabolomics and Imaging Mass Spectrometry
Proteomics of Diseases and Precision Medicine
Protein Complexes and Interactomics
Proteomics in Immunology and Infectious Disease (COVID-19)
Quantitative Proteomics and Systems Biology
Structural Proteomics, and Native MS
Top-Down Proteomics, and Proteoform Biology
Stem Cell Proteomics
The submitting author must be the same person who will present the abstract at the Conference, and will be expected to register and pay to attend. A limited number of abstracts will be selected for oral presentations. Abstracts selected for oral presentations are also required to present a poster presentation.
Deadlines and Procedures
Abstract submissions for oral presentation consideration closed on Friday, 4 December 2021.
Poster presentation consideration will be accepted through Friday, 15 January 2021 at 23:59 Pacific Standard Time.
You may submit more than one abstract for review. However, each submission must be completed in full before a new abstract submission can be started.
Acknowledgement of receipt of abstract will be sent to the presenting author's email upon completion of submission.
The Organizing Committee reserves the right to accept or decline all submissions and to select the presentation format.
Selected oral abstract presenting authors will be notified of acceptance status and format of the presentation by Friday, 8 January 2021.
Poster abstract presenting authors will be notified of their acceptance status by Wednesday, 3 February 2021.
Presenters must register to attend the conference by Friday, 22 January 2021.
ABSTRACT SUBMISSION PROCEDURE
Click here and then simply follow the instructions and prompts on the submission site to complete your abstract submission.
Read and accept the Deadlines and Procedures Agreement.
Enter Presenting/Submitting Author information. This is the person who will receive all abstract correspondence.
Enter Additional Authors information. Authors’ names will appear in the order they were entered in the submission site. The primary author’s name will be underlined and their email address published in the abstract book.
Please do not enter information, such as author’s names, contact information or abstract titles in all capital letters. Capitalize letters only where necessary.
Enter your abstract title in title case. (This Is a Sample of Title Case.) Titles are limited to 150 characters.
Select your presentation type (oral and poster or poster only) and oral and poster topics.
Copy and paste your abstract into the space provided.
Review your abstract. Confirm all special characters are showing correctly and that the abstract did not exceed the 300-word limit. Words exceeding the 300-word limit will be excluded from the abstract.
Save your abstract by clicking the “Submit” button on the bottom of the screen. You can return and edit your abstract at any time prior to the deadline.
ACCEPTANCE OF ABSTRACTS
Compliance with all stated conditions including adherence to the deadline is required. Acknowledgement of receipt of completed abstracts will be sent via email upon submission.
The abstract submission period closes on Friday, 15 January 2021.
The Conference Organizers reserves the right to decide whether a submission will be accepted, and the right to determine the presentation form.
For questions regarding abstract submission, please contact: